E. M. Miller

Liposomal Combination Drug and siRNA Delivery to Combat Drug-Resistant Ovarian Cancer

E. M. Miller, 2018 .

"The Utility of Rivaroxaban as Primary Venous Thromboprophylaxis in an Adult Trauma Population".

S. Savage, E. M. Miller, Lisa K. Kingdon, 2019, The Journal of surgical research.

Nanoparticle delivery systems to combat drug resistance in ovarian cancer.

Angela A Alexander-Bryant, E. M. Miller, T. Samec, 2020, Nanomedicine : nanotechnology, biology, and medicine.

Corticosteroid Use in Severely Hypoxemic COVID-19 Patients: An Observational Cohort Analysis of Dosing Patterns and Outcomes in the Early Phase of the Pandemic

R. Kruer, C. Terry, E. M. Miller, 2020, medRxiv.

Implementation of Multimodal Pain Protocol Associated With Opioid Use Reduction in Trauma Patients.

Christopher B. Robbins, A. Meagher, E. M. Miller, 2022, The Journal of surgical research.